Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 22,200 shares, a decline of 30.0% from the July 31st total of 31,700 shares. Based on an average trading volume of 3,200 shares, the days-to-cover ratio is presently 6.9 days. Currently, 0.2% of the company’s stock are sold short.

NYSEAMERICAN XTNT traded down $0.04 during mid-day trading on Wednesday, reaching $2.70. 2,000 shares of the company’s stock traded hands, compared to its average volume of 7,266. Xtant Medical has a 1-year low of $1.61 and a 1-year high of $4.88.

Xtant Medical (NYSEAMERICAN:XTNT) last posted its quarterly earnings data on Thursday, August 8th. The medical device company reported ($0.15) earnings per share (EPS) for the quarter. The business had revenue of $15.27 million during the quarter.

Separately, Maxim Group cut Xtant Medical from a “buy” rating to a “hold” rating in a research note on Friday, May 17th.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc, formerly Bacterin International Holdings, Inc, develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.

Featured Article: What Factors Can Affect Return on Equity?

Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.